Literature DB >> 3793006

Epidemiologic aspects of Santa Marta hepatitis over a 40-year period.

B Buitrago, S C Hadler, H Popper, S N Thung, M A Gerber, R H Purcell, J E Maynard.   

Abstract

"Santa Marta" hepatitis has been recognized as an unusual type of severe hepatitis occurring in northern Colombia since 1930. Liver specimens from a historic viscerotomy series, used by Gast-Galvis to identify cases and describe epidemiologic features of this disease, were available for review and histopathologic staining for delta-virus. Of 86 liver specimens examined from cases of fulminant Santa Marta hepatitis, 81 showed a distinct histopathologic picture, in various stages of progression, with features of eosinophilic necrosis, microvesicular fat infiltration of the liver parenchyma and morula cells; 69% were positive for delta-antigen by immunoperoxidase staining. This disease occurred predominantly in several small towns within 50 km of Santa Marta, with mortality reaching 1.25 per 1,000 inhabitants per year during the 1940's. Children under age 15 were most commonly affected and males affected twice as frequently as females. Liver specimens obtained from children, or within 15 hr of death, or which showed early histologic stages of disease were most likely to be positive for delta-antigen. This and the accompanying study confirm the existence of a distinct type of fulminant hepatitis in Colombia for over 50 years. The epidemiologic and histopathologic features are comparable to severe hepatitis in Venezuela Indians and in the Amazon basin of Brazil, suggesting that all are caused by delta-superinfection of hepatitis B virus carriers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3793006     DOI: 10.1002/hep.1840060611

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation?

Authors:  Mónica Viviana Alvarado-Mora; María Fernanda Gutierrez Fernandez; Michele Soares Gomes-Gouvêa; Raymundo Soares de Azevedo Neto; Flair José Carrilho; João Renato Rebello Pinho
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

2.  Five-Year Eradication of Hepatitis B Infection After an Outreach Immunization Program in the Waorani Population in the Ecuadorian Amazon.

Authors:  Edy Quizhpe; Gladys Ñauta; Juan Antonio Córdoba-Doña; Enrique Teran
Journal:  Am J Trop Med Hyg       Date:  2016-07-05       Impact factor: 2.345

3.  A genotype of hepatitis D virus that occurs in northern South America.

Authors:  J L Casey; T L Brown; E J Colan; F S Wignall; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

Review 4.  HDV Pathogenesis: Unravelling Ariadne's Thread.

Authors:  Eirini D Tseligka; Sophie Clément; Francesco Negro
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

5.  Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia.

Authors:  Diana di Filippo Villa; Fabian Cortes-Mancera; Edra Payares; Neyla Montes; Fernando de la Hoz; Maria Patricia Arbelaez; Gonzalo Correa; Maria-Cristina Navas
Journal:  Virol J       Date:  2015-10-24       Impact factor: 4.099

6.  Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults.

Authors:  Narcisse Patrice Komas; Sumantra Ghosh; Mariama Abdou-Chekaraou; Pierre Pradat; Nasser Al Hawajri; Alexandre Manirakiza; Gina Laure Laghoe; Claudine Bekondi; Ségolène Brichler; Jean-Omer Ouavéné; Abdoulaye Sépou; Brice Martial Yambiyo; Jean Chrysostome Gody; Valentin Fikouma; Athénais Gerber; Natali Abeywickrama Samarakoon; Dulce Alfaiate; Caroline Scholtès; Nora Martel; Frédéric Le Gal; Hugo Lo Pinto; Ikram Amri; Olivier Hantz; David Durantel; Jean-Louis Lesbordes; Emmanuel Gordien; Philippe Merle; Tudor Drugan; Christian Trépo; Fabien Zoulim; Jean-Claude Cortay; Alan Campbell Kay; Paul Dény
Journal:  PLoS Negl Trop Dis       Date:  2018-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.